Repository logo
 

Single-Cell Landscape of Transcriptional Heterogeneity and Cell Fate Decisions during Mouse Early Gastrulation

Published version
Peer-reviewed

Type

Article

Change log

Authors

Mohammed, H 
Hernando-Herraez, I 
Savino, A 
Scialdone, A 
Macaulay, I 

Abstract

The mouse inner cell mass (ICM) segregates into the epiblast and primitive endoderm (PrE) lineages coincident with implantation of the embryo. The epiblast subsequently undergoes considerable expansion of cell numbers prior to gastrulation. To investigate underlying regulatory principles, we performed systematic single-cell RNA sequencing (seq) of conceptuses from E3.5 to E6.5. The epiblast shows reactivation and subsequent inactivation of the X chromosome, with Zfp57 expression associated with reactivation and inactivation together with other candidate regulators. At E6.5, the transition from epiblast to primitive streak is linked with decreased expression of polycomb subunits, suggesting a key regulatory role. Notably, our analyses suggest elevated transcriptional noise at E3.5 and within the non-committed epiblast at E6.5, coinciding with exit from pluripotency. By contrast, E6.5 primitive streak cells became highly synchronized and exhibit a shortened G1 cell-cycle phase, consistent with accelerated proliferation. Our study systematically charts transcriptional noise and uncovers molecular processes associated with early lineage decisions.

Description

Keywords

X-chromosome, embryo, epiblast, gastrulation, primitive endoderm, primitive streak, single-cell RNA-seq, transcriptional noise

Journal Title

Cell Reports

Conference Name

Journal ISSN

2211-1247
2211-1247

Volume Title

20

Publisher

Elsevier
Sponsorship
Wellcome Trust (105031/D/14/Z)
Medical Research Council (MC_PC_12009)
Cancer Research UK (22231)
This project was funded by a Wellcome Trust Strategic Award 105031/D/14/Z awarded to W.R., S. Teichmann, J.N., B. Simons, T.V., S. Srinivas, L. Vallier, B. Goettgens, and J.C.M. W.R. is additionally supported by the BBSRC (BB/K010867/1) and the Wellcome Trust (095645/Z/11/Z), and T.V. is supported by KU Leuven (SymBioSys, PFV/10/016).